| Code | Description | Claims | Beneficiaries | Total Paid |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12,203 |
9,584 |
$821K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,464 |
7,371 |
$271K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,511 |
1,875 |
$266K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
30,566 |
25,103 |
$204K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,327 |
1,820 |
$190K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,200 |
1,912 |
$127K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,957 |
1,562 |
$122K |
| 93015 |
|
2,340 |
1,793 |
$122K |
| 93000 |
|
9,837 |
8,557 |
$98K |
| 93296 |
|
1,948 |
1,717 |
$17K |
| 99215 |
Prolong outpt/office vis |
193 |
170 |
$11K |
| 93294 |
|
840 |
692 |
$8K |
| 93295 |
|
350 |
257 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
266 |
227 |
$6K |
| 93244 |
|
215 |
184 |
$3K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
23 |
18 |
$2K |
| 99152 |
|
281 |
234 |
$2K |
| 93356 |
|
794 |
623 |
$2K |
| 93242 |
|
94 |
79 |
$541.22 |
| 93308 |
|
13 |
12 |
$354.79 |
| 93018 |
|
13 |
13 |
$217.13 |